Document is current
Any future updates will be listed below
-
Authors
Hayashino, Kenta
Fujii, Nobuharu https://orcid.org/0000-0002-8043-7768
Nagano, Tomohiro
Ikeda, Daisuke
Fujiwara, Kanako
Hashida, Risa
Kitamura, Wataru
Kobayashi, Hiroki
Kondo, Takumi
Seike, Keisuke
Fujiwara, Hideaki
Asada, Noboru
Ennishi, Daisuke
Fujii, Keiko
Matsuoka, Ken-ichi
Maeda, Yoshinobu
- License Information
-
More Information
Article History
Received: 23 September 2024
Revised: 20 January 2025
Accepted: 22 January 2025
First Online: 4 February 2025
Declarations
:
: All procedures performed in the study were in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The use of rituximab, bortezomib, and tocilizumab in this case was approved by the Institutional Review Board.
: The authors declare that they have no conflicts of interests. Daisuke Ennishi is editor of International Journal of Hematology.
